Director Dan Wolterman receives 52,600 Hyperfine (HYPR) stock options at $1.49

Rhea-AI Filing Summary

Hyperfine, Inc. director Dan Wolterman received a grant of stock options covering 52,600 shares of Class A common stock. The options have an exercise price of $1.49 per share and expire on June 3, 2036. These options vest at the issuer's next regular annual stockholders meeting, subject to his continued service through that date.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Wolterman Dan

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Options (right to buy)	52,600	$0.00	--

Holdings After Transaction: Stock Options (right to buy) — 52,600 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Options granted: 52,600 options Exercise price: $1.49 per share Expiration date: June 3, 2036 +1 more

4 metrics

Options granted 52,600 options Stock options for Class A common stock granted to director

Exercise price $1.49 per share Strike price for newly granted stock options

Expiration date June 3, 2036 Option term end for granted stock options

Post-grant derivative holdings 52,600 options Total stock options held after reported transaction

Key Terms

Stock Options (right to buy), exercise price, expiration date, vesting

4 terms

Stock Options (right to buy) financial

"security_title: "Stock Options (right to buy)""

exercise price financial

"conversion_or_exercise_price: "1.4900""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration_date: "2036-06-03T00:00:00.000Z""

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

vesting financial

"shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wolterman Dan

(Last) (First) (Middle)

C/O HYPERFINE, INC.

351 NEW WHITFIELD STREET

(Street)

GUILFORD CONNECTICUT 06437

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hyperfine, Inc. [ HYPR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (right to buy)	$1.49	06/03/2026		A		52,600		(1)	06/03/2036	Class A Common Stock	52,600	$0	52,600	D

Explanation of Responses:

1. The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Mr. Wolterman's continued service through the applicable vesting date.

	/s/ Brett Hale, Attorney-in-Fact	06/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Hyperfine (HYPR) director Dan Wolterman report on this Form 4?

Dan Wolterman reported receiving a grant of stock options for 52,600 shares of Hyperfine Class A common stock. These options were awarded at no cost and are documented as an acquisition of derivative securities on the Form 4.

What is the exercise price of Dan Wolterman’s new Hyperfine (HYPR) stock options?

The granted stock options have an exercise price of $1.49 per share. This means Wolterman can purchase Hyperfine Class A common stock at $1.49 per share once the options vest and before they expire, subject to the grant’s terms.

When do Dan Wolterman’s Hyperfine (HYPR) stock options vest?

The options vest on the date of Hyperfine’s next regular annual stockholders meeting. Vesting is conditioned on Wolterman’s continued service with the company through that meeting date, as described in the Form 4 footnote.

When do the newly granted Hyperfine (HYPR) stock options expire?

The stock options granted to Dan Wolterman expire on June 3, 2036. He may exercise them at $1.49 per share any time after vesting and before this expiration date, consistent with the award’s terms.

How many Hyperfine (HYPR) derivative securities does Dan Wolterman hold after this grant?

Following this grant, Wolterman holds 52,600 stock options as reported in the Form 4. This figure reflects his total options position from this filing, as there are no additional derivative holdings listed in the derivative summary.